510(k) Report

PMA · Approved

Approved

RealTime CMV Assay

P160044/S005PMAApproved Jan 13, 202324-day reviewClass II21 CFR 866.3180

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Molecular · PAB Cytomegalovirus (Cmv) Dna Quantitative Assay

Approved on Jan 13, 2023 through premarket approval, which rests on the device’s own clinical evidence after a 24-day review.

Decided
Jan 13, 2023
Review
24 days
Class
Class II
Product code
PAB
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

FIG. 1 — Lineage of P160044/S005Source: FDA PMA database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PAB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PAB device

  1. #1 K252481 cobas CMVscore 10.3 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All PAB devices

PAB Cytomegalovirus (Cmv) Dna Quantitative Assay: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · PAB

3in 2025

2012: 32013: 102014: 42015: 82016: 72017: 132018: 242019: 212020: 82021: 42022: 92023: 142024: 162025: 3
2007high 24 (2018) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PAB

88in 2025

2025: 88 days median
2007high 88 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PAB

No recall names PAB since 2007.

Adverse event reports per year · PAB

4in 2025

2014: 12015: 22016: 12017: 12018: 22019: 12022: 12023: 32024: 22025: 4
2007high 4 (2025) · low 0 (2007)2025

MAUDE reports naming product code PAB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20123—00
201310—00
20144—01
20158—02
20167—01
201713—01
201824—02
201921—01
20208—00
20214—00
20229—01
202314—03
202416—02
202538804
20260—0—
Cite this page

510(k) Report. “P160044/S005: RealTime CMV Assay.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/P160044/S005

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026